Contraline
Charlottesville
About Contraline
Contraline is developing the first long-lasting, non-hormonal, reversible contraceptive for men
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $24.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2022)
- Website: contraline.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/contraline-3600 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.